Streetbeat News

Equity Actions

RKT

Rocket Companies has appointed Heather Lovier as the new Chief Operating Officer, replacing Bill Emerson, who will continue to serve as the company's President.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:44 pm

CRKN

Crown Electrokinetics (CRKN) issued a letter to shareholders detailing a 1:150 reverse split to maintain Nasdaq compliance, and provided revenue guidance for Q2 and Q3. The company highlighted growth in its Fiber Optics division and progress in its Electrokinetic Film division.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:44 pm

TNXP

Tonix Pharmaceuticals has announced a proposed public offering, though the size of the offering has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:41 pm

OP

OceanPal's 13D filing reveals that Eleftherios Papatrifon has reported a 5.42% stake in the company as of June 24, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:37 pm

ATER

Aterian has appointed Arturo Rodriguez as CEO and Josh Feldman as CFO. Joe Risico has resigned as Co-CEO and from the Board of Directors but will consult the company during a three-month transition period.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:31 pm

PRFX

On June 24, PainReform announced that Ilan Hadar, the CEO and CFO, has ceased his service to the company. Ehud Geller has been appointed as the interim CEO and CFO, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:25 pm

RXRX

Recursion Pharmaceuticals shares are trading lower after the company announced a $200 million proposed offering.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:19 pm

JEF

Jefferies Financial Group (JEF) has announced a 16.7% increase in its quarterly dividend, raising it from $0.30 to $0.35 per share. The dividend will be payable on August 30, 2024, to shareholders of record as of August 19, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:18 pm

ADUS

Addus HomeCare shares are trading lower following the announcement of a proposed public offering of 1.50 million shares of its common stock.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:15 pm

CASI

CASI Pharmaceuticals shares are trading higher following the announcement of a $15 million private placement financing.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 8:14 pm